Literature DB >> 8683142

Antigen-receptor engagement in B cells induces nuclear expression of STAT5 and STAT6 proteins that bind and transactivate an IFN-gamma activation site.

J G Karras1, Z Wang, S J Coniglio, D A Frank, T L Rothstein.   

Abstract

The signal transducer and activator of transcription (STAT) family of transcription factors is triggered by cytokine and growth factor receptors in a number of cell types, and binds to a consensus sequence defined in part by the IFN-gamma activation site (GAS). It is not known whether these transcription factors respond to other kinds of growth stimuli, and, with particular relevance to lymphocytes, it is not known whether STAT proteins participate in Ag-specific responses. To determine the role of STAT proteins, coupling between Ag-receptor cross-linking and nuclear expression of DNA-binding protein complexes that recognize GAS sequences was evaluated. Ag-receptor triggering in primary B lymphocytes stimulated nuclear expression of a complex that specifically binds the IFN response factor-1 (IRF-1) GAS sequence, and is distinguished by electrophoretic mobility and GAS preference from IRF-1 GAS-binding complexes induced by IFN-gamma. Activation of nuclear IRF-1 GAS-binding activity by sIg was inhibited by the tyrosine kinase inhibitor, herbimycin A, and binding activity was eliminated by tyrosine phosphatase treatment. Activation of IRF-1 GAS-binding activity was blocked by depletion of protein kinase C. The IRF-1 GAS-binding activity induced by sIg engagement in B cells was transcriptionally active, and was found to consist of immunoreactive STAT5 and STAT6 proteins. This work demonstrates that the STAT signaling pathway previously associated with cytokine signaling is triggered in B lymphocytes through Ag-receptor engagement in a protein kinase C-dependent fashion. This heretofore described cytokine signaling pathway may play a role in bringing about Ag-specific proliferative and differentiative responses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8683142

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  STAT signaling in the pathogenesis and treatment of cancer.

Authors:  D A Frank
Journal:  Mol Med       Date:  1999-07       Impact factor: 6.354

2.  Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1.

Authors:  S J Haque; Q Wu; W Kammer; K Friedrich; J M Smith; I M Kerr; G R Stark; B R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

3.  Regulation of telomerase activity by interferon regulatory factors 4 and 8 in immune cells.

Authors:  Radmila Hrdlicková; Jirí Nehyba; Henry R Bose
Journal:  Mol Cell Biol       Date:  2008-12-01       Impact factor: 4.272

4.  A novel gene coding for a Fas apoptosis inhibitory molecule (FAIM) isolated from inducibly Fas-resistant B lymphocytes.

Authors:  T J Schneider; G M Fischer; T J Donohoe; T P Colarusso; T L Rothstein
Journal:  J Exp Med       Date:  1999-03-15       Impact factor: 14.307

5.  Signal transducer and activator of transcription-3 (STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes.

Authors:  J G Karras; Z Wang; L Huo; R G Howard; D A Frank; T L Rothstein
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

6.  Heterogeneity of signal transducer and activator of transcription binding sites in the long-terminal repeats of distinct HIV-1 subtypes.

Authors:  Andrea Crotti; Giulia D Chiara; Silvia Ghezzi; Rossella Lupo; Rienk E Jeeninga; Elio Liboi; Patricia M-J Lievens; Elisa Vicenzi; Chiara Bovolenta; Ben Berkhout; Guido Poli
Journal:  Open Virol J       Date:  2007-10-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.